http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04410a71b41dd14cad960a606335717c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Biessen |
| name | Erik A.L. Biessen Erik AL Biessen Erik A.L Biessen |
| given-name | Erik A.L. Erik AL Erik A.L |
| organization-name | From the Division of Biopharmaceutics (C.C.M.A., B.C.H.L., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Leiden University, Gorlaeus Laboratories, Leiden, the Netherlands, and Center for Molecular and Vascular Biology (A.B., K.D., M.F.H), University of Leuven, Leuven, Belgium. Department of Pathology, Maastricht University Medical Center, P Debyelaan 25, 6229 HX Maastricht, The Netherlands. From the Division of Biopharmaceutics (I.B., S.C.A.d.J., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Leiden, the Netherlands; Institute of Molecular Cardiovascular Research (A.Z., C.W.), University Hospital, Rheinisch-Westfälische Technische Hochschule, Aachen, Germany; Wihuri Research Institute (K.A.L.), Helsinki, Finland. From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research (J.H.v.d.T., M.L.F., T.J.C.v.B., E.A.L.B.), Gorlaeus Laboratories, Department of Cardiology, Leiden University Medical Centre (J.H.v.d.T.), and Crucell Holland B.V. (R.P., A.J.v.Z., V.M.), 2333 CN Leiden, The Netherlands. From the Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM) (E.M., T.L.T., J.A.F.D., M.J., M.v.G., R.V., A.J., J.P.C., M.M.D., M.J.G., E.A.L.B., J.C.S.), Department of Clinical Chemistry (S.J.R.M.), Department of Toxicology (G.R.H.), Department of Internal Medicine, CARIM (C.G.S.), Department of Radiation Oncology (Maastro Lab), GROW (L.J.D., P.L.), Department of Molecular Genetics, CARIM (M.J.G.), Department of Biochemistry, CARIM (J.W.M.H.), Department of Pharmacology,... From the Diabetic Complications Laboratory (S.P.G., E.D.M., K.K., P.C., M.E.C., K.A.M.J.-D.), Epigenetics Laboratory (J.O., A.E.-O.), and Diabetes and Dyslipidaemia Group (A.C.C.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Faculty of Medicine, Monash University, Melbourne, Australia (S.P.G., E.D.M., K.A.M.J.-D.); Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands (E.A.L.B.); Institute of Cardiovascular and Medical Sciences, University of... From the Institut für Klinische Chemie und Laboratoriumsmedizin, Westfälische Wilhelms-Universität, Münster, Germany (J.-R.N., G.A.), Leibniz-Institut für Arterioskleroseforschung an der Universität Münster, Münster, Germany (J.-R.N., G.A.), Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, the Netherlands (M. Bot, T.v.B., E.A.L.B.), Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin, Experimentelle und Klinische... Department of Pathology Maastricht University Maastricht The Netherlands 4Experimental Vascular Pathology Group, Cardiovascular Research Institute Maastricht, GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands. Department of Pathology Maastricht University Cardiovascular Research Institute Maastricht Maastricht The Netherlands From the Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, the Netherlands (E.P.C.v.d.V., E.A.L.B., M.M.P.C.D.), RWTH Aachen University, Germany; Institute for Molecular Cardiovascular Research (IMCAR) (E.P.C.v.d.V., E.A.L.B.), RWTH Aachen University, Germany From the Division of Biopharmaceutics (E.J.A.v.W., S.C.A.d.J., T.v.E., P.d.V., E.A.L.B., T.J.C.v.B., J.K.), Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands; and UCB (H.L.B., D.A.O., R.J.W., G.A.C.), Granta Park, Great Abington, Cambridge, UK. From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands (F.M.E.S., I.B., E.P.v.d.V., T.J.C.v.B., E.A.L.B.); Department of Anatomy and Embryology (B.d.A., L.M.v.d.G., R.E.P., L.v.d.W.), Department of Radiology (L.v.d.W.), and Department of Human Genetics (L.v.d.W.), Leiden University Medical Center, Leiden, The Netherlands; Department of Research, Guerbet Group, Aulnay-sous-Bois, France (W.G., I.R.); Department of Medical... From the Molecular Cardiology Laboratory, Experimental Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands (C.C. R. Haasdijk, E.H.M.v.d.K., R. Herpers, F.B., W.K.D.D., L.A.J.B., R.d.J., P.E.B., I.C., H.J.D.); Hubrecht Institute-KNAW & UMC Utrecht, the Netherlands (R. Herpers, F.B., S.S.-M.); Experimental Vascular Pathology Group, Department of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands (E.A.L.B.); and Molecular Cardiology,... Cardiovascular Research Institute Maastricht University Medical Center (CARIM) Maastricht University Maastricht The Netherlands; Department of Pathology Maastricht University Maastricht The Netherlands; Institute for Molecular Cardiovascular Research (IMCAR) Universitätsklinikum Aachen Aachen Germany Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, 2333CC Leiden, Netherlands 1; Experimental Pathology, CARIM, Academic University Hospital Maastricht, 6200MD Maastricht, Netherlands 8 From the Division of Biopharmaceutics (I.B., J.H.v.d.T., M.L.F., S.C.A.d.J., Th.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Leiden, the Netherlands; John P. Robarts Research Institute (A.L.), Vascular Biology Research Group, University of Western Ontario, London, Ontario, Canada; and the Department of Pathology (M.M.P.C.D., S.H., M.J.A.P.D.), Cardiovascular Research Institute Maastricht, University of Maastricht, the Netherlands. From the Einthoven Laboratory of Experimental Vascular Medicine (E.P.v.d.V., R.G.d.B., M.R.d.V., S.T., J.M.v.G., M.K.R., C.M.B., C.v.S., H.C.d.B., E.A.P., R.B., T.J.R., P.H.A.Q., J.W.J, A.J.v.Z.), and the Departments of Nephrology (E.P.v.d.V., R.G.d.B., J.M.v.G., M.K.R., C.v.S., H.C.d.B., R.B., T.J.R., A.J.v.Z.), Cardiology (A.O.K., S.T., J.S., M.J.S., A.A.F.d.V., J.W.J), Surgery (M.R.d.V., I.B., E.A.P., P.H.A.Q.), Pulmonology (T.P., P.S.H.), and Molecular and Cellular Biology (M.J.G.), Leiden... From the Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands (M.F.C., A.P., W.V., P.C., G.S., M.H., R.L., B.S., S.H.); Santaris Pharma A/S, Hørsholm, Denmark (M.L., S.O., S.K.); Department of Bioinformatics (BiGCaT), Maastricht University, The Netherlands (S.L.M.C.); Department of Molecular Genetics, CARIM, Maastricht University, The Netherlands (M.J.J.G., M.P.J.W.); Department of Medical Biochemistry, Academic Medical... From the Division of Biopharmaceutics (H.Y., T.J.C.v., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Leiden University, the Netherlands; and Leiden Institute of Chemistry (K.S., H.O., G.A.v.), Gorlaeus Laboratories, Leiden University, the Netherlands. From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Sylvius Laboratories, Leiden University, Leiden, The Netherlands (J.H.v.d.T., T.J.C.v.B., E.A.L.B.); and the Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands (J.H.v.d.T.). From the Molecular Cardiology Laboratory, Experimental Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands (C.C., D.T., W.K.D.D., R.H., I.C., F.L.B., K.W., E.v.d.K., L.B., P.W.S., H.J.D.); Hubrecht's Institute-KNAW and University Medical Centre, Utrecht, The Netherlands (F.L.B., S.S.-M.); the Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands (E.A.L.B.); and the Departments of Vascular Surgery (F.M.) and Cardiology (G.P.),... Cardiovascular Research Institute Maastricht, Experimental Vascular Pathology, Department of Pathology Maastricht University Medical Centre+ Maastricht the Netherlands; Institute for Molecular Cardiovascular Research RWTH Aachen University Aachen Germany From the Experimental Vascular Pathology and Cardiovascular Research Institute Maastricht (CARIM), Department of Pathology, Maastricht University, The Netherlands (V.H., E.A.L.B., C.B., S.H.); Department of Immune Therapeutics, Merck Sharp & Dohme, Oss, The Netherlands (D.D.); Department of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA (M.L.); Department of Pathology M2-206, Academic Medical Centre, Amsterdam, The Netherlands (M.J.D.); and Department of Medicine and Pathology... From the Division of Biopharmaceutics (J.H.v.d.T., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research; Molecular Virology Group, Department of Molecular Cell Biology (R.C.H.) and Department of Cardiology (J.H.v.d.T.), Leiden University Medical Center; and TNO-PG (B.J.M.v.V., L.M.H.), Leiden, the Netherlands; and Department of Pathology (M.M.K.), Middelheim Academic Hospital, Antwerp, Belgium. From the Division of Biopharmaceutics (I.B., S.C.A.d.J., M.B., S.H.v.H., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University; Departments of Cardiology (P.d.G.) and Pathology (R.W.V.), Medisch Centrum Haaglanden, The Hague; Department of Pathology (J.H.v.d.T.), Academic Medical Center, Amsterdam; and Experimental Vascular Pathology Group (E.A.L.B.), Department of Pathology, University of Maastricht, The Netherlands. From the Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands (A.C., L.T., B.L., E.A.L.B.); Department of Cell Biology, Institute for Biomedical Engineering, Aachen University Hospital, Aachen, Germany (A.C.); and Department of Pathology, Amsterdam Medical Center, Amsterdam, The Netherlands (M.J.A.P.D.). From the Division of Biopharmaceutics (H.Y., I.B., M.B., S.H.v.H., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, the Netherlands; Leiden Institute of Chemistry (K.S., X.X., G.A.v.d.M., H.O.), Gorlaeus Laboratories, Leiden University, Leiden, the Netherlands; Division of Cardiovascular Medicine (M.R.B.), University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom; Department of Pathology (E.A.L.B.), University Hospital Maastricht,... From the Division of Biopharmaceutics (A.D.H., G.H.M.P., N.P., P.d.V., E.J.A.v.W., E.A.L.B., T.J.C.v.B., J.K.), Leiden University, The Netherlands; the Department of Biosciences, TNO Quality of Life, Gaubius Laboratory, and the Department of Vascular Surgery (V.v.W., P.H.A.Q.), LUMC, Leiden, the Netherlands; the Department of Radiation Oncology (A.G.N.), Heidelberg School of Medicine, Heidelberg, Germany; and The Scripps Research Institute (R.A.R.), La Jolla, Calif. the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, University of Leiden (E.A.L.B., M.v.T., H.V., M.K.B., T.J.C.v.B., J.K.), and Gaubius Laboratory, TNO Prevention and Health (M.M.B.-B., D.C.R.), Leiden, The Netherlands. From the Division of Biopharmaceutics, Leiden-Amsterdam Center for Drug Research, Sylvius Laboratory, University of Leiden (the Netherlands). From the Division of Biopharmaceutics (P.C.N.R., L.A.J.M.S., P.J.v.S., M.F., S.H.v.L., T.J.C.v.B., E.A.L.B.), Leiden/Amsterdam Center for Drug Research, University of Leiden, Gorlaeus Laboratory, Leiden; the Department of Industrial Design (H.N.J.S.), Delft University of Technology, Delft; Central Clinical Chemical Laboratory of the Leiden University Medical Center (J.H.M.S.), Leiden; and the Department of General Internal Medicine (P.C.N.R. current address), Leiden University Medical Center, Leiden... From the Bristol Heart Institute (C.L.J., J.L.J.), University of Bristol, UK; the University of Cambridge (M.R.B.), UK; the University of Leiden (E.A.L.B.), The Netherlands; and Laboratory of Physiology (R.K.), Free University Amsterdam, The Netherlands. Maastricht University Medical Center, Maastricht, the Netherlands (M.A.C.F., L.T., E.A.L.B., J.C.S., A.H.B.). From the Department of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands (E.A.L.B.); Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA (A.C.). the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands. Department of Pathology; Institute for Molecular Cardiovascular Research (IMCAR), University Hospital RWTH, Aachen, Aachen, Germany From the Department of General Surgery, Maastricht University, Maastricht, the Netherlands (F.M.E.S.); Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom (H.Y.); Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, the Netherlands (F.M.E.S., T.J.M.M., P.P., T.J.C.v.B., E.A.L.B.); Department of Material Science, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso-chou, Nagoya... From the Experimental Vascular Pathology group, Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, The Netherlands (I.T.M.N.D., A.C., L.T., S.S.M., T.S., M.M., M.R., M.P., M.D., E.L., E.A.L.B.); the Department of Cell Biology, Institute for Biomedical Engineering, Aachen University Hospital, Aachen, Germany (A.C.); Bioceros, Utrecht, The Netherlands (L.B.); the Department of Pathology, Amsterdam Medical Center, Amsterdam, The Netherlands (C.v.d.L., M.D.); Institute... From the Departments of Medical Biochemistry (P.I.B., T.W.H.P., C.M.v.T., M.V., E.K.A., J.R., H.P., C.J.M.d.V.), Cardiology (E.K.A., K.T.K., R.J.d.W.), and Clinical Epidemiology, Biostatistics, and Bioinformatics (M.W.T.T.), Academic Medical Center, University of Amsterdam, Amsterdam; Department of Hematology, Erasmus University Medical Center, Rotterdam (M.P.M.d.M.); Department of Pathology, Maastricht University Medical Center, Maastricht (E.A.L.B.); and Division of Biopharmaceutics, Leiden... From Experimental Vascular Pathology Group, Department of Pathology, CARIM, Maastricht University Medical Center, The Netherlands (I.M., J.S., I.W., V.H., M.G., J.C., E.A.L.B.); Division of Biopharmaceutics, Leiden Academic Center for Drug Research, Leiden University, The Netherlands (I.M., I.B., S.C.A.d.J., T.J.C.v.B.); CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France (C.C., I.M.-P.); Université de Toulouse, France (C.C., I.M.-P.); Institute for Prevention of... From the Division of Biopharmaceutics, Leiden Academic Center for Drug Research, Leiden, the Netherlands (S.C.A.d.J., I.B., A.O.K., S.J.A.K., M.B., P.J.v.S., T.J.C.v.B., J.K., E.A.L.B.); Department of Cardiology, Leiden University Medical Center, the Netherlands (A.O.K.); Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands (S.J.A.K.); and Experimental Vascular Pathology group, Department of Pathology, CARIM, Academic... |
Incoming Links
Total number of triples: 154.